Glucose enhances expression of TRPC1 and calcium entry in endothelial cells

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 298, Issue 1, 2010, Pages

  Bishara, N B ^a   Ding, H ^b  

^a RMIT UNIVERSITY   (Australia)

^b WEILL CORNELL MEDICAL COLLEGE   (Qatar)

Author keywords

Bovine aorta endothelial cells; Diabetes; Endothelial dysfunction; Hyperglycemia; Store operated calcium entry; Transient receptor potential channel antisense; Transient receptor potential channels

Indexed keywords

1 [2 (4 METHOXYPHENYL) 2 [3 (4 METHOXYPHENYL)PROPOXY]ETHYL] 1H IMIDAZOLE; 2 AMINOETHOXYDIPHENYLBORANE; ADENOSINE TRIPHOSPHATE; ANTISENSE OLIGODEOXYNUCLEOTIDE; CALCIUM; GADOLINIUM; GLUCOSE; TRANSIENT RECEPTOR POTENTIAL CHANNEL 1; TRANSIENT RECEPTOR POTENTIAL CHANNEL 3; TRANSIENT RECEPTOR POTENTIAL CHANNEL 4; TRANSIENT RECEPTOR POTENTIAL CHANNEL 6;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; ARTICLE; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; CELL FUNCTION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; COW; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; GLUCOSE HOMEOSTASIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING;

ADENOSINE TRIPHOSPHATE; ANIMALS; ANTISENSE ELEMENTS (GENETICS); ARACHIDONIC ACID; BLOTTING, WESTERN; BORON COMPOUNDS; CALCIUM; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS; CALCIUM SIGNALING; CATTLE; CELLS, CULTURED; ENDOTHELIAL CELLS; GADOLINIUM; GLUCOSE; IMIDAZOLES; INDICATORS AND REAGENTS; TRPC CATION CHANNELS;

EID: 73549103572     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00699.2009     Document Type: Article

References (58)

1. Abdullaev IF, Bisaillon JM, Potier M, Gonzalez JC, Motiani RK, Trebak M. Stim1 and Orai1 mediate CRAC currents and store-operated calcium entry important for endothelial cell proliferation. Circ Res 103: 1289-1299, 2008.
2. 2+ entry in endothelial cells. J Biol Chem 279: 20941-20949, 2004.
3. Andrews KL, Pannirselvam M, Anderson TJ, Jenkins AJ, Triggle CR, Hill MA. The vascular endothelium in diabetes: a practical target for drug treatment? Expert Opin Ther Targets 9: 101-117, 2005.
4. 2+ entry in vascular endothelial cells is mediated via pathways sensitive to 2 aminoethoxydiphenyl borate and xestospongin C. Br J Pharmacol 135: 119-128, 2002.
5. 2+ entry in cultured bovine endothelial cells. Endothelium 12: 153-161, 2005.
6. 2+ entry in vascular smooth muscle cells. J Pharmacol Exp Ther 317: 488-499, 2006.
7. 2+ entry. Nat Cell Biol 6: 669-677, 2009.
8. Chang AS, Chang SM, Garcia RL, Schilling WP. Concomitant and hormonally regulated expression of trp genes in bovine aortic endothelial cells. FEBS Lett 415: 335-340, 1997.
9. Chung AW, Au Yeung K, Chum E, Okon EB, van Breemen C. Diabetes modulates capacitative calcium entry and expression of transient receptor potential canonical channels in human saphenous vein. Eur J Pharmacol 613: 114-118, 2009.
10. Clapham DE. TRP channels as cellular sensors. Nature 426: 517-524, 2003.
11. Cosentino F, Hishikawa K, Katusic ZS, Luscher TF. High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells. Circulation 96: 25-28, 1997.
12. Cosentino F, Eto M, De Paolis P, van der Loo B, Bachschmid M, Ullrich V, Kouroedov A, Delli Gatti C, Joch H, Volpe M, Lüscher TF. High glucose causes upregulation of cyclooxygenase-2 and alters prostanoid profile in human endothelial cells: role of protein kinase C and reactive oxygen species. Circulation 107: 1017-1023, 2003.
13. De Vriese AS, Verbeuren TJ, Van de Voorde J, Lameire NH, Vanhoutte PM. Endothelial dysfunction in diabetes. Br J Pharmacol 130: 963-274, 2000.
14. Delmas P, Wanaverbecq N, Abogadie FC, Mistry M, Brown DA. Signaling microdomains define the specificity of receptor-mediated InsP(3) pathways in neurons. Neuron 34: 209-220, 2002.
15. Dietrich A, Kalwa H, Rost BR, Gudermann T. The diacylgylcerol-sensitive TRPC3/6/7 subfamily of cation channels: functional characterization and physiological relevance. Pflügers Arch 451: 72-80, 2005.
16. Ding H, Hashem M, Wiehler WB, Lau W, Martin J, Reid J, Triggle CR. Endothelial dysfunction in the streptozotocin-induced diabetic apoE-deficient mouse. Br J Pharmacol 146: 1110-1118, 2005.
17. Ding H, Aljofan M, Triggle CR. Oxidative stress and increased eNOS and NADPH oxidase expression in mouse microvessel endothelial cells. J Cell Physiol 212: 682-689, 2007.
18. Ding Y, Vaziri ND, Coulson R, Kamanna VS, Roh DD. Effects of simulated hyperglycemia, insulin, and glucagon on endothelial nitric oxide synthase expression. Am J Physiol Endocrinol Metab 279: E11-E17, 2000.
19. Du XL, Edelstein D, Dimmeler S, Ju Q, Sui C, Brownlee M. Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site. J Clin Invest 108: 1341-1348, 2001.
20. Feletou M, Vanhoutte PM. Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture). Am J Physiol Heart Circ Physiol 291: H985-H1002, 2006.
21. 2+ inflow system by gadolinium and SK&F 96365. Biochim Biophys Acta 1222: 383-389, 1994.
22. Franzius D, Hoth M, Penner R. Non-specific effects of calcium entry antagonists in mast cells. Pflügers Arch 428: 433-448, 1994.
23. -/- mice. Nat Cell Biol 3: 121-127, 2001.
24. Hink U, Li H, Mollnau H, Oelze M, Matheis E, Hartmann M, Skatchkov M, Thaiss F, Stahl RA, Warnholtz A, Meinertz T, Griendling K, Harrison DG, Forstermann U, Munzel T. Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ Res 88: E14-E22, 2001.
25. 2+ influx in vascular endothelial cells. J Cell Biochem 108: 499-507, 2009.
26. Huang GN, Zeng W, Kim JY, Yuan JP, Han L, Muallem S, Worley PF. STIM1 carboxyl-terminus activates native SOC, I(crac) and TRPC1 channels. Nat Cell Biol 8: 1003-1010, 2006.
27. Idris I, Donnelly R. Protein kinase C beta inhibition: a novel therapeutic strategy for diabetic microangiopathy. Diab Vasc Dis Res 3: 172-178, 2006.
28. Kumar B, Dreja K, Shah SS, Cheong A, Xu SZ, Sukumar P, Naylor J, Forte A, Cipollaro M, McHugh D, Kingston PA, Heagerty AM, Munsch CM, Bergdahl A, Hultgårdh-Nilsson A, Gomez MF, Porter KE, Hellstrand P, Beech DJ. Upregulated TRPC1 channel in vascular injury in vivo and its role in human neointimal hyperplasia. Circ Res 98: 557-563, 2006.
29. Lee C, Xu DZ, Feketeova E, Kannan KB, Fekete Z, Deitch EA, Livingston DH, Hauser CJ. Store-operated calcium channel inhibition attenuates neutrophil function and postshock acute lung injury. J Trauma 59: 56-63, 2005.
30. 2+ entry via NCX reversal in ATP stimulated smooth muscle cells. Biochem Biophys Res Commun 352: 130-134, 2007.
31. Luckhoff A, Busse R. Calcium influx into endothelial cells and formation of endothelium-derived relaxing factor is controlled by the membrane potential. Pflügers Arch 416: 305-311, 1990.
32. Mathiesen ER, Hilsted J, Feldt-Rasmussen B, Bonde-Petersen F, Christensen NJ, Parving HH. The effect of metabolic control on hemodynamics in short-term insulin-dependent diabetic patients. Diabetes 34: 1301-1305, 1985.
33. Mene P, Pugliese G, Pricci F, Di Mario U, Cinotti GA, Pugliese F. High glucose inhibits cytosolic calcium signaling in cultured rat mesangial cells. Kidney Int 43: 585-591, 1993.
34. Moore TM, Brough GH, Babal P, Kelly JJ, Li M, Stevens T. Store-operated calcium entry promotes shape change in pulmonary endothelial cells expressing Trp1. Am J Physiol Lung Cell Mol Physiol 275: L574-L582, 1998.
35. Niehof M, Borlak J. HNF4 alpha and the Ca-channel TRPC1 are novel disease candidate genes in diabetic nephropathy. Diabetes 57: 1069-1077. 2008.
36. Nilius B, Viana F, Droogmans G. Ion channels in vascular endothelium. Annu Rev Physiol 59: 145-170, 1997.
37. Nilius B, Droogmans G. Ion channels and their functional role in vascular endothelium. Physiol Rev 81: 1415-1459, 2001.
38. Ong HL, Cheng KT, Liu X, Bandyopadhyay BC, Paria BC, Soboloff J, Pani B, Gwack Y, Srikanth S, Singh BB, Gill DL, Ambudkar IS. Dynamic assembly of TRPC1-STIM1-Orai1 ternary complex is involved in store-operated calcium influx. Evidence for similarities in store-operated and calcium release-activated calcium channel components. J Biol Chem 282: 9105-9116, 2007.
39. 2+ entry (SOCE). J Biol Chem 283: 17333-17340, 2008.
40. Pannirselvam M, Simon V, Verma S, Anderson T, Triggle CR. Chronic oral supplementation with sepiapterin prevents endothelial dysfunction and oxidative stress in small mesenteric arteries from diabetic (db/db) mice. Br J Pharmacol 140: 701-706, 2003.
41. Parekh AB, Penner R. Store depletion and calcium influx. Physiol Rev 77: 901-930, 1997.
42. Parekh AB, Putney JW Jr. Store-operated calcium channels. Physiol Rev 85: 757-810, 2005.
43. Pedersen SF, Owsianik G, Nilius B. TRP channels: an overview. Cell Calcium 38: 233-252, 2005.
44. Poburko D, Lhote P, Szado T, Behra T, Rahimian R, McManus B, van Breemen C, Ruegg UT. Basal calcium entry in vascular smooth muscle. Eur J Pharmacol 505: 19-29, 2004.
45. Putney JW. Pharmacology of capacitative calcium entry. Mol Interv 1: 84-94, 2001.
46. Salameh A, Dhein S. Influence of chronic exposure to high concentrations of D-glucose and long-term beta-blocker treatment on intracellular calcium concentrations of porcine aortic endothelial cells. Diabetes 47: 407-413, 1998.
47. Salt IP, Morrow VA, Brandie FM, Connell JM, Petrie JR. High glucose inhibits insulin-stimulated nitric oxide production without reducing endothelial nitric-oxide synthase Ser1177 phosphorylation in human aortic endothelial cells. J Biol Chem 278: 18791-18797, 2003.
48. Sank A, Wei D, Reid J, Ertl D, Nimni M, Weaver F, Yellin A, Tuan TL. Human endothelial cells are defective in diabetic vascular disease. J Surg Res 57: 647-653, 1994.
49. Sheng JZ, Wang D, Braun AP. DAF-FM (4-amino-5-methylamino- 2′,7′-difluorofluorescein) diacetate detects impairment of agonist-stimulated nitric oxide synthesis by elevated glucose in human vascular endothelial cells: reversal by vitamin C and L-sepiapterin. J Pharmacol Exp Ther 315: 931-940, 2005.
50. Tamareille S, Mignen O, Capiod T, Rucker-Martin C, Feuvray D. High glucose-induced apoptosis through store-operated calcium entry and calcineurin in human umbilical vein endothelial cells. Cell Calcium 39: 47-55, 2006.
51. Tilton RG, Chang K, Hasan KS, Smith SR, Petrash JM, Misko TP, Moore WM, Currie MG, Corbett JA, McDaniel ML, Williamson JR. Prevention of diabetic vascular dysfunction by guanidines: inhibition of nitric oxide synthase versus advanced glycation end-product formation. Diabetes 42: 221-232, 1993.
52. Triggle CR, Howarth A, Cheng ZJ, Ding H. Twenty-five years since the discovery of endothelium-derived relaxing factor (EDRF): does a dysfunctional endothelium contribute to the development of type 2 diabetes? Can J Physiol Pharmacol 83: 681-700, 2005.
53. Tsien RW, Tsien RY. Calcium channels, stores, and oscillations. Annu Rev Cell Biol 6: 715-760, 1990.
54. van Breemen C, Poburko D, Okon EB. TRP proteins: a new dimension in the treatment of occlusive vascular disease. Circ Res 98: 446-447, 2006.
55. Vanhoutte PM. Endothelium and control of vascular function. State of the Art lecture. Hypertension 13: 658-667, 1998.
56. Várnai P, Hunyady L, Balla T. STIM and Orai: the long-awaited constituents of store-operated calcium entry. Trends Pharmacol Sci 30: 118-128, 2009.
57. 2+ response and EDRF formation in vascular endothelial cells. Diabetes 43: 984-991, 1994.
58. Zbidi H, López JJ, Amor NB, Bartegi A, Salido GM, Rosado JA. Enhanced expression of STIM1/Orai1 and TRPC3 in platelets from patients with type 2 diabetes mellitus. Blood Cells Mol Dis 43: 211-3, 2009.